Arriving at a detailed understanding of the role of the microbiome in human health and disease requires a precise characterization of the bacteria that comprise the human microbiome. To achieve that goal requires application of a set of consistent, standardized practices to ensure conformity between, and across, researchers and companies. At present, there are no widely agreed upon and accepted standards or best practices for sample collection and handling, sequencing standards, collation of reference databases or data collection and manipulation.   

There are already numerous public and private groups working on these issues. TMBC hopes to be a positive force in this area by facilitating the conversation between these groups and the companies that will play a key role in translating findings in this space to diagnostics, therapeutics, adjunct therapies and direct-to-consumer services and products.